Cargando…

Infections and diabetes: Risks and mitigation with reference to India

BACKGROUND AND AIMS: The link between diabetes and increased risk of infectious disease has long been recognized, but has re-entered sharp focus following the COVID-19 pandemic. METHODS: A literature search was conducted in PubMed for articles in English on diabetes and infection. RESULTS: Diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Unnikrishnan, Ranjit, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505871/
https://www.ncbi.nlm.nih.gov/pubmed/33002780
http://dx.doi.org/10.1016/j.dsx.2020.09.022
_version_ 1783584905178906624
author Unnikrishnan, Ranjit
Misra, Anoop
author_facet Unnikrishnan, Ranjit
Misra, Anoop
author_sort Unnikrishnan, Ranjit
collection PubMed
description BACKGROUND AND AIMS: The link between diabetes and increased risk of infectious disease has long been recognized, but has re-entered sharp focus following the COVID-19 pandemic. METHODS: A literature search was conducted in PubMed for articles in English on diabetes and infection. RESULTS: Diabetes predisposes to infections through alterations in innate and acquired immune defenses. Outcomes of infection are worse in people with uncontrolled diabetes, and infection can worsen hyperglycemia in hitherto well controlled diabetes (bidirectional relationship). Diabetes does not increase the risk of infection with COVID-19 per se, but predisposes to severe disease and poor outcomes. COVID-19 has also been linked to deterioration of glycemic control as well as new-onset diabetes. CONCLUSIONS: Clinicians caring for people with diabetes should be aware of the increased risk of infections in this population, as well as the possibility of worsening hyperglycemia. A holistic approach with frequent monitoring of blood glucose levels and appropriate titration of medications, along with close attention to nutritional status, is essential to ensure the best possible outcomes.
format Online
Article
Text
id pubmed-7505871
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Diabetes India. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75058712020-09-23 Infections and diabetes: Risks and mitigation with reference to India Unnikrishnan, Ranjit Misra, Anoop Diabetes Metab Syndr Article BACKGROUND AND AIMS: The link between diabetes and increased risk of infectious disease has long been recognized, but has re-entered sharp focus following the COVID-19 pandemic. METHODS: A literature search was conducted in PubMed for articles in English on diabetes and infection. RESULTS: Diabetes predisposes to infections through alterations in innate and acquired immune defenses. Outcomes of infection are worse in people with uncontrolled diabetes, and infection can worsen hyperglycemia in hitherto well controlled diabetes (bidirectional relationship). Diabetes does not increase the risk of infection with COVID-19 per se, but predisposes to severe disease and poor outcomes. COVID-19 has also been linked to deterioration of glycemic control as well as new-onset diabetes. CONCLUSIONS: Clinicians caring for people with diabetes should be aware of the increased risk of infections in this population, as well as the possibility of worsening hyperglycemia. A holistic approach with frequent monitoring of blood glucose levels and appropriate titration of medications, along with close attention to nutritional status, is essential to ensure the best possible outcomes. Diabetes India. Published by Elsevier Ltd. 2020 2020-09-22 /pmc/articles/PMC7505871/ /pubmed/33002780 http://dx.doi.org/10.1016/j.dsx.2020.09.022 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Unnikrishnan, Ranjit
Misra, Anoop
Infections and diabetes: Risks and mitigation with reference to India
title Infections and diabetes: Risks and mitigation with reference to India
title_full Infections and diabetes: Risks and mitigation with reference to India
title_fullStr Infections and diabetes: Risks and mitigation with reference to India
title_full_unstemmed Infections and diabetes: Risks and mitigation with reference to India
title_short Infections and diabetes: Risks and mitigation with reference to India
title_sort infections and diabetes: risks and mitigation with reference to india
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505871/
https://www.ncbi.nlm.nih.gov/pubmed/33002780
http://dx.doi.org/10.1016/j.dsx.2020.09.022
work_keys_str_mv AT unnikrishnanranjit infectionsanddiabetesrisksandmitigationwithreferencetoindia
AT misraanoop infectionsanddiabetesrisksandmitigationwithreferencetoindia